# Denali Therapeutics Inc.: Form DEF 14A, filed Apr 22, 2021

- Company: [Denali Therapeutics Inc.](/companies/dnli.md) (CIK 1714899)
- Form: DEF 14A
- Filed: 2021-04-22
- Accepted by EDGAR: Apr 22, 2021, 08:46 ET
- Period: 2021-06-02
- Accession: 0001714899-21-000042
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000042/fy20def14aproxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000042/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1714899/000171489921000042/fy20def14aproxy.htm

Filed Apr 22, 2021.
Source: SEC EDGAR, the filing index for accession 0001714899-21-000042. Last ingested by Listed: Nov 3, 2026, 19:01 ET. No prices; not investment advice.
